Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat
<p>Abstract</p> <p>Background</p> <p>Previous studies suggest that the cyclooxygenase-2 (COX-2) inhibitor nimesulide has a remarkable protective effect against different types of brain injury including ischemia. Since there are no reports on the effects of nimesulide on...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-01-01
|
| Series: | Journal of Neuroinflammation |
| Online Access: | http://www.jneuroinflammation.com/content/2/1/3 |
| _version_ | 1811247934376771584 |
|---|---|
| author | Muñoz Eduardo García-Cabrera Michel González-Falcón Armando Mhadu Noël H Candelario-Jalil Eduardo León Olga Fiebich Bernd L |
| author_facet | Muñoz Eduardo García-Cabrera Michel González-Falcón Armando Mhadu Noël H Candelario-Jalil Eduardo León Olga Fiebich Bernd L |
| author_sort | Muñoz Eduardo |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Previous studies suggest that the cyclooxygenase-2 (COX-2) inhibitor nimesulide has a remarkable protective effect against different types of brain injury including ischemia. Since there are no reports on the effects of nimesulide on permanent ischemic stroke and because most cases of human stroke are caused by permanent occlusion of cerebral arteries, the present study was conducted to assess the neuroprotective efficacy of nimesulide on the cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion (pMCAO) in the rat.</p> <p>Methods</p> <p>Ischemia was induced by permanent occlusion of the middle cerebral artery in rats, <it>via </it>surgical insertion of a nylon filament into the internal carotid artery. Infarct volumes (cortical, subcortical and total) and functional recovery, assessed by neurological score evaluation and rotarod performance test, were performed 24 h after pMCAO. In initial experiments, different doses of nimesulide (3, 6 and 12 mg/kg; i.p) or vehicle were administered 30 min before pMCAO and again at 6, 12 and 18 h after stroke. In later experiments we investigated the therapeutic time window of protection of nimesulide by delaying its first administration 0.5–4 h after the ischemic insult.</p> <p>Results</p> <p>Repeated treatments with nimesulide dose-dependently reduced cortical, subcortical and total infarct volumes as well as the neurological deficits and motor impairment resulting from permanent ischemic stroke, but only the administration of the highest dose (12 mg/kg) was able to significantly (P < 0.01) diminish infarct volume. The lower doses failed to significantly reduce infarction but showed a beneficial effect on neurological function. Nimesulide (12 mg/kg) not only reduced infarct volume but also enhanced functional recovery when the first treatment was given up to 2 h after stroke.</p> <p>Conclusions</p> <p>These data show that nimesulide protects against permanent focal cerebral ischemia, even with a 2 h post-treatment delay. These findings have important implications for the therapeutic potential of using COX-2 inhibitors in the treatment of stroke.</p> |
| first_indexed | 2024-04-12T15:18:07Z |
| format | Article |
| id | doaj.art-2792f358f895411f9a394d83c074f396 |
| institution | Directory Open Access Journal |
| issn | 1742-2094 |
| language | English |
| last_indexed | 2024-04-12T15:18:07Z |
| publishDate | 2005-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Neuroinflammation |
| spelling | doaj.art-2792f358f895411f9a394d83c074f3962022-12-22T03:27:33ZengBMCJournal of Neuroinflammation1742-20942005-01-0121310.1186/1742-2094-2-3Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the ratMuñoz EduardoGarcía-Cabrera MichelGonzález-Falcón ArmandoMhadu Noël HCandelario-Jalil EduardoLeón OlgaFiebich Bernd L<p>Abstract</p> <p>Background</p> <p>Previous studies suggest that the cyclooxygenase-2 (COX-2) inhibitor nimesulide has a remarkable protective effect against different types of brain injury including ischemia. Since there are no reports on the effects of nimesulide on permanent ischemic stroke and because most cases of human stroke are caused by permanent occlusion of cerebral arteries, the present study was conducted to assess the neuroprotective efficacy of nimesulide on the cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion (pMCAO) in the rat.</p> <p>Methods</p> <p>Ischemia was induced by permanent occlusion of the middle cerebral artery in rats, <it>via </it>surgical insertion of a nylon filament into the internal carotid artery. Infarct volumes (cortical, subcortical and total) and functional recovery, assessed by neurological score evaluation and rotarod performance test, were performed 24 h after pMCAO. In initial experiments, different doses of nimesulide (3, 6 and 12 mg/kg; i.p) or vehicle were administered 30 min before pMCAO and again at 6, 12 and 18 h after stroke. In later experiments we investigated the therapeutic time window of protection of nimesulide by delaying its first administration 0.5–4 h after the ischemic insult.</p> <p>Results</p> <p>Repeated treatments with nimesulide dose-dependently reduced cortical, subcortical and total infarct volumes as well as the neurological deficits and motor impairment resulting from permanent ischemic stroke, but only the administration of the highest dose (12 mg/kg) was able to significantly (P < 0.01) diminish infarct volume. The lower doses failed to significantly reduce infarction but showed a beneficial effect on neurological function. Nimesulide (12 mg/kg) not only reduced infarct volume but also enhanced functional recovery when the first treatment was given up to 2 h after stroke.</p> <p>Conclusions</p> <p>These data show that nimesulide protects against permanent focal cerebral ischemia, even with a 2 h post-treatment delay. These findings have important implications for the therapeutic potential of using COX-2 inhibitors in the treatment of stroke.</p>http://www.jneuroinflammation.com/content/2/1/3 |
| spellingShingle | Muñoz Eduardo García-Cabrera Michel González-Falcón Armando Mhadu Noël H Candelario-Jalil Eduardo León Olga Fiebich Bernd L Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat Journal of Neuroinflammation |
| title | Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| title_full | Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| title_fullStr | Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| title_full_unstemmed | Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| title_short | Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| title_sort | effects of the cyclooxygenase 2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat |
| url | http://www.jneuroinflammation.com/content/2/1/3 |
| work_keys_str_mv | AT munozeduardo effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT garciacabreramichel effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT gonzalezfalconarmando effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT mhadunoelh effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT candelariojalileduardo effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT leonolga effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat AT fiebichberndl effectsofthecyclooxygenase2inhibitornimesulideoncerebralinfarctionandneurologicaldeficitsinducedbypermanentmiddlecerebralarteryocclusionintherat |